Skip to main content
Erschienen in: Supportive Care in Cancer 5/2020

05.09.2019 | Original Article

Cross-sectional areas of rectus abdominis and psoas muscles reduces following surgery in rectal cancer patients

verfasst von: Oguz Yuksel, Naciye Sinem Gezer, Aras Emre Canda, Hakki Celik, Birsu Topcugil, Merve Demir Benli, Tayfun Bisgin, Zumre Arican Alicikus, Funda Obuz

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the trophic changes in rectus abdominis and psoas muscles in patients who underwent open or laparoscopic rectum resection for rectal cancer.

Methods

We retrospectively analyzed preoperative staging computerized tomographies (CT) and postoperative first oncological follow-up CTs of the patients who underwent low anterior resection (LAR) for rectal cancer from 2010 through 2015. We measured cross-sectional area of left and right rectus abdominis muscles from two levels (above and below umbilicus) where they are widest and psoas muscle at mid-level of the fourth lumbar vertebral body in axial CT images and compared preoperative and postoperative measurements. We investigated the effects of age, sex, administration of preoperative chemoradiotherapy (CRT), type of surgery (open or laparoscopic), or construction of a diverting ileostomy on cross-sectional muscle area changes.

Results

After applying inclusion and exclusion criteria 60 patients found to be eligible for the study. Muscle areas of all measurement sites were reduced postoperatively compared to paired preoperative values. There was no significant effect of age, sex, administration of preoperative CRT, type of surgery (open or laparoscopic), or construction of a diverting ileostomy to muscle cross-sectional area reductions.

Conclusion

Cross-sectional areas of the rectus abdominis and the psoas muscles of rectal cancer patients reduces following rectum resection which indicates atrophy of these muscles. Clinicians should be aware of this problem and focus on prevention of muscle atrophy during the treatment of rectal cancer patients.
Literatur
9.
10.
Zurück zum Zitat Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–495. https://doi.org/10.1016/S1470-2045(10)70218-7 CrossRefPubMed Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–495. https://​doi.​org/​10.​1016/​S1470-2045(10)70218-7 CrossRefPubMed
14.
18.
24.
Zurück zum Zitat Thompson M, Trainor B (2005) Incidence of parastomal hernia before and after a prevention programme. Gastrointest Nurs 3(2):23–27 Thompson M, Trainor B (2005) Incidence of parastomal hernia before and after a prevention programme. Gastrointest Nurs 3(2):23–27
31.
Zurück zum Zitat Dall'Acqua AM, Sachetti A, Santos LJ, Lemos FA, Bianchi T, Naue WS, Dias AS, Sbruzzi G, Vieira SR (2017) Use of neuromuscular electrical stimulation to preserve the thickness of abdominal and chest muscles of critically ill patients: a randomized clinical trial. J Rehabil Med 49(1):40–48. https://doi.org/10.2340/16501977-2168 CrossRef Dall'Acqua AM, Sachetti A, Santos LJ, Lemos FA, Bianchi T, Naue WS, Dias AS, Sbruzzi G, Vieira SR (2017) Use of neuromuscular electrical stimulation to preserve the thickness of abdominal and chest muscles of critically ill patients: a randomized clinical trial. J Rehabil Med 49(1):40–48. https://​doi.​org/​10.​2340/​16501977-2168 CrossRef
33.
Zurück zum Zitat Morielli AR, Usmani N, Boulé NG, Tankel K, Severin D, Nijjar T, Joseph K, Courneya KS (2016) A phase I study examining the feasibility and safety of an aerobic exercise intervention in patients with rectal cancer during and after neoadjuvant chemoradiotherapy. Oncol Nurs Forum 43(3):352–362. https://doi.org/10.1188/16.ONF.352-362 CrossRefPubMed Morielli AR, Usmani N, Boulé NG, Tankel K, Severin D, Nijjar T, Joseph K, Courneya KS (2016) A phase I study examining the feasibility and safety of an aerobic exercise intervention in patients with rectal cancer during and after neoadjuvant chemoradiotherapy. Oncol Nurs Forum 43(3):352–362. https://​doi.​org/​10.​1188/​16.​ONF.​352-362 CrossRefPubMed
Metadaten
Titel
Cross-sectional areas of rectus abdominis and psoas muscles reduces following surgery in rectal cancer patients
verfasst von
Oguz Yuksel
Naciye Sinem Gezer
Aras Emre Canda
Hakki Celik
Birsu Topcugil
Merve Demir Benli
Tayfun Bisgin
Zumre Arican Alicikus
Funda Obuz
Publikationsdatum
05.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05062-y

Weitere Artikel der Ausgabe 5/2020

Supportive Care in Cancer 5/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.